New Haven biotech acquires drug candidate for severe anemia for $3 million
The drug candidate, RLYB331, is being developed to treat patients with severe anemia from certain blood disorders |!| New Haven
More from Greater New Haven
New Haven Register
Yale football falls to Rhode Island despite Hugo Djeumeni Kemeni's 243-yard rushing game
Greater New Haven
•
2m ago
Southern Connecticut State Owls
SCSU Women's Soccer Falls To Saint Anselm
Greater New Haven
•
11m ago
New Haven Chargers
New Haven's Defense Stifles Robert Morris, Powers Blue & Gold to 26-15 Victory
Greater New Haven
•
1h ago
New Haven Register
Police seek information after 3 people threw food or liquid at man near Beth-El Shelter in Milford
Greater New Haven
•
2h ago